Bibliographic Details
Title: |
Genetic Variants in RASSF1 (rs2073498), SERPINE1 (rs1799889), and EFNA1 (rs12904) Are Associated with Susceptibility in Mexican Patients with Colorectal Cancer: Clinical Associations and Their Analysis In Silico. |
Authors: |
Tovar-Jácome, César de Jesús1 (AUTHOR) cesartovjacome@gmail.com, Juárez-Vázquez, Clara Ibet2 (AUTHOR) clara.juarez@edu.uag.mx, Gallegos-Arreola, Martha Patricia3 (AUTHOR) marthapatriciagallegos08@gmail.com, García-Ortiz, José Elías3 (AUTHOR) jose.elias.garcia@gmail.com, Marín-Contreras, María Eugenia4 (AUTHOR) meugeniamarinc@yahoo.com.mx, Pineda-Razo, Tomás Daniel5 (AUTHOR) dan.pinena.razo@gmail.com, Mariscal-Ramírez, Ignacio5 (AUTHOR) ignacio.mariscal@imss.gob.mx, Durán-Anguiano, Oscar6 (AUTHOR) droscardurananguiano@gmail.com, Alcaraz-Wong, Aldo Antonio7 (AUTHOR) draldoalcarazw@hotmail.com, González-Sánchez, Rubria Alicia1 (AUTHOR) rubria18@gmail.com, Mundaca-Rodríguez, Marina Lizbeth1 (AUTHOR) tosti2306@gmail.com, Godínez-Rodríguez, Miriam Yadira1 (AUTHOR) ya_dirita@hotmail.com, Corona-Padilla, Marlín1 (AUTHOR) marlinmd2202@gmail.com, Rosales-Reynoso, Mónica Alejandra1 (AUTHOR) mareynoso77@yahoo.com.mx |
Source: |
Genes. Feb2025, Vol. 16 Issue 2, p223. 16p. |
Subject Terms: |
*COLORECTAL cancer, *GENE expression profiling, *GENETIC variation, *DISEASE risk factors, *DISEASE susceptibility |
Abstract: |
Background/Objectives: Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Variants in genes that regulate processes such as apoptosis and angiogenesis play a significant role in CRC. The objective of this study is to investigate the possible association between RASSF1 (rs2073498), SERPINE1 (rs1799889), EFNA1 (rs12904), and RAD51 (rs1801320) variants and clinicopathological characteristics of Mexican patients with CRC. Methods: DNA of peripheral blood samples was obtained from 631 individuals (349 patients and 282 control individuals). The RASSF1 (rs2073498), SERPINE1 (rs1799889), EFNA1 (rs12904), and RAD51 (rs1801320) variants were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The association was calculated using the odds ratio (OR) test. p-values were adjusted by the Bonferroni test (0.0125). In silico analysis programs, including Combined Annotation Dependent Depletion (CADD), Polymorphism Phenotyping-2 (PolyPhen-2), and Gene Expression Profiling Interactive Analysis (GEPIA), were conducted to predict the functional impact of these variants. Results: Patients carrying the G/A genotype of the RASSF1 (rs2073498) variant showed an association with CRC characteristics, including TNM stages and tumor location (OR > 2.5, p = 0.001). Regarding the SERPINE1 (rs1799889) variant, patients carrying the 5G/4G genotype showed an association between TNM stages and tumor location in the rectum (OR > 1.5, p ≤ 0.05). Patients with the G/G genotype for the EFNA1 (rs12904) variant showed an association with TNM stages and rectal tumor location (OR > 2.0, p = 0.001). The RAD51 (rs1801320) variant had no association with colorectal cancer. Conclusions: RASSF1 (rs2073498), SERPINE1 (rs1799889), and EFNA1 (rs12904) variants significantly influence colorectal cancer risk. [ABSTRACT FROM AUTHOR] |
|
Copyright of Genes is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Academic Search Complete |